About Fischer Medical Ventures Limited
Data last updated: 10 January 2026
Fischer Medical Ventures Limited is a public limited company based in Pedagantyada, Andhra Pradesh, India. It specialises in chemical distribution and retail, a part of the broader chemicals and materials sector. Incorporated on 22 March 1993, the company has been in operation for over 33 years.
Registered with ROC Vijayawada under CIN L86900AP1993PLC118162. Listed on BSE: 524743.
Capital: an authorised share capital of ₹80 Cr and a paid-up capital of ₹64.85 Cr. Formerly known as Fischer Chemic Limited. It is led by directors including Jaya Ankur Singhania and Ravindran Govindan.
Last AGM: 29 September 2025. Financial statements filed for year ended 31 March 2025. Office: Pedagantyada, Andhra Pradesh.
As per the financials filed for FY 2023, the company reported a revenue of ₹17.95 Lakh.
As per MCA filings, the company has open charges of ₹25 Cr and satisfied charges of ₹20.63 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website fischerchemic.in.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered AddressSurvey No. 480/2 Ap Medtech Zone Nadupura Village, Pedagantyadu Mandal Visakhapatnam, Pedagantyada, Andhra Pradesh, India – 530031
-
IndustryChemicals and Materials, Chemical Distribution & Retail
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L86900AP1993PLC118162, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L86900AP1993PLC118162 | Current |
| L24231TN1993PLC024661 | Previous |
| L86900MH1993PLC288371 | Previous |
| L24231MH1993PLC288371 | Previous |
Business Activity of Fischer Medical Ventures Limited
Fischer Medical Ventures Limited operates primarily in the trade sector. The company has 1 registered business activity segment, reflecting its diverse operational portfolio.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| ********* | Trade | ********* | Wholesale Trading | ********* |
Auditor Details of Fischer Medical Ventures Limited
Fischer Medical Ventures Limited is audited by Bilimoria Mehta & Co (ICAI peer reviewed, certificate valid till 2027-06-30) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| Bilimoria Mehta & Co (ICAI peer reviewed, certificate valid till 2027-06-30) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Fischer Medical Ventures Limited
Fischer Medical Ventures Limited is currently managed by 10 directors, with 28 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Jaya Ankur Singhania
Also directs:
Avabodha Bharat Legal Advisory & Training Llp, J S Singhania And Co. Llp, Sudarshan Pharma Industries Limited and 5 more
|
Director | 26 Mar 2025 | 1 Years 3 Months | Current |
| Ravindran Govindan | Managing Director | 04 May 2024 | 2 Years 2 Months | Current |
| Svetlana Rao Raviwada | Whole-Time Director | 04 May 2024 | 2 Years 2 Months | Current |
| Sanjay Jayantilal Jain | Director | 12 Oct 2021 | 4 Years 9 Months | Current |
|
Khairy Jamaluddin Abu Bakar
Also directs:
Fischer Medical Ventures Limited
|
Director | 04 May 2024 | 2 Years 2 Months | Current |
|
Roberto Mamangon Pagdanganan
Also directs:
Fischer Medical Ventures Limited
|
Director | 05 Jul 2024 | 2 Years 0 Months | Current |
Financials of Fischer Medical Ventures Limited FY 2026 filings available
Fischer Medical Ventures Limited reported revenue of ₹308.58 Cr (up ) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 |
|---|---|
| Revenue from Operations | ₹308.58 Cr |
| Other Income | ₹12.31 Cr |
| Total Income | ₹320.89 Cr |
| Cost of Materials Consumed | ₹62.24 Cr |
| Purchases of Stock-in-Trade | ₹83.49 Cr |
| Changes in Inventories | -₹3.16 Cr |
| Employee Benefit Expense | ₹15.09 Cr |
| Finance Costs | ₹5.83 Cr |
| Depreciation & Amortisation | ₹2.98 Cr |
| Other Expenses | ₹107.82 Cr |
| Total Expenses | ₹274.31 Cr |
| Profit Before Exceptional Items & Tax | ₹46.58 Cr |
| Exceptional Items | ₹0 |
| Profit Before Tax | ₹46.58 Cr |
| Total Tax Expense | ₹15.34 Cr |
| Net Profit | ₹31.02 Cr |
| Other Comprehensive Income | ₹5.43 Lakh |
| Total Comprehensive Income | ₹31.07 Cr |
| EBITDA (computed) | ₹55.4 Cr |
| Basic EPS | ₹0.48 |
| Diluted EPS | ₹0.45 |
| Metrics | FY 2026 |
|---|---|
| Total Assets | ₹671.01 Cr |
| Non-current Assets | ₹253.42 Cr |
| Current Assets | ₹417.59 Cr |
| Property, Plant & Equipment | ₹12.48 Cr |
| Inventories | ₹12.66 Cr |
| Trade Receivables | ₹288.8 Cr |
| Cash & Equivalents | ₹11.89 Cr |
| Equity (Net Worth) | ₹385.14 Cr |
| Equity Share Capital | ₹65.45 Cr |
| Borrowings (Non-current) | ₹26.09 Lakh |
| Borrowings (Current) | ₹72.1 Cr |
| Total Debt (computed) | ₹72.36 Cr |
| Current Liabilities | ₹258.03 Cr |
| Total Liabilities | ₹285.87 Cr |
| Metrics | FY 2026 |
|---|---|
| Operating Cash Flow | -₹101.27 Cr |
| Investing Cash Flow | -₹5.22 Cr |
| Financing Cash Flow | ₹14.11 Cr |
| Capital Expenditure | ₹1.31 Cr |
| Free Cash Flow (computed) | -₹102.58 Cr |
| Dividends Paid | ₹27.44 Lakh |
| Net Change in Cash | -₹92.37 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|---|---|---|---|
| Revenue from Operations | ₹97.73 Cr | ₹101.1 Cr | ₹86.31 Cr | ₹23.44 Cr |
| Other Income | ₹1.28 Cr | ₹1.09 Cr | ₹2.48 Cr | ₹7.47 Cr |
| Total Income | ₹99.01 Cr | ₹102.18 Cr | ₹88.79 Cr | ₹30.91 Cr |
| Cost of Materials Consumed | ₹62.09 Cr | ₹0 | ₹14.89 Lakh | ₹7.58 Cr |
| Purchases of Stock-in-Trade | ₹6.9 Cr | ₹57.81 Cr | ₹11.2 Cr | ₹0 |
| Changes in Inventories | -₹53.55 Lakh | -₹8.92 Cr | ₹1.34 Cr | ₹4.96 Cr |
| Employee Benefit Expense | ₹4.02 Cr | ₹4.17 Cr | ₹3.75 Cr | ₹3.16 Cr |
| Finance Costs | ₹3.61 Cr | ₹63.71 Lakh | ₹91.87 Lakh | ₹66.99 Lakh |
| Depreciation & Amortisation | ₹92.57 Lakh | ₹77.01 Lakh | ₹51.37 Lakh | ₹76.97 Lakh |
| Other Expenses | ₹24.24 Cr | ₹26.47 Cr | ₹53.62 Cr | ₹3.48 Cr |
| Total Expenses | ₹101.26 Cr | ₹80.94 Cr | ₹71.48 Cr | ₹20.62 Cr |
| Profit Before Exceptional Items & Tax | -₹2.25 Cr | ₹21.25 Cr | ₹17.3 Cr | ₹10.29 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹2.25 Cr | ₹21.25 Cr | ₹17.3 Cr | ₹10.29 Cr |
| Total Tax Expense | ₹4.86 Cr | ₹1.95 Cr | ₹3.37 Cr | ₹5.17 Cr |
| Net Profit | -₹7.12 Cr | ₹19.23 Cr | ₹13.9 Cr | ₹5.01 Cr |
| attributable to Owners | - | ₹7.38 Lakh | -₹78,000 | - |
| attributable to NCI | - | -₹13.12 Lakh | -₹65,000 | - |
| Other Comprehensive Income | ₹0 | ₹0 | ₹6.32 Lakh | ₹0 |
| Total Comprehensive Income | -₹7.12 Cr | ₹19.23 Cr | ₹13.96 Cr | ₹5.01 Cr |
| EBITDA (computed) | ₹2.28 Cr | ₹22.65 Cr | ₹18.74 Cr | ₹11.73 Cr |
| Basic EPS | ₹-0.11 | ₹0.30 | ₹2.15 | ₹0.77 |
| Diluted EPS | ₹0.10 | ₹0.29 | ₹2.11 | ₹0.76 |
| Metrics | FY 2026 |
|---|---|
| Revenue from Operations | ₹17.39 Cr |
| Other Income | ₹3.49 Cr |
| Total Income | ₹20.89 Cr |
| Cost of Materials Consumed | ₹0 |
| Purchases of Stock-in-Trade | ₹11.96 Cr |
| Changes in Inventories | -₹35.45 Lakh |
| Employee Benefit Expense | ₹2.02 Cr |
| Finance Costs | ₹4.65 Cr |
| Depreciation & Amortisation | ₹67.86 Lakh |
| Other Expenses | ₹12.44 Cr |
| Total Expenses | ₹31.39 Cr |
| Profit Before Exceptional Items & Tax | -₹10.51 Cr |
| Exceptional Items | ₹0 |
| Profit Before Tax | -₹10.51 Cr |
| Total Tax Expense | -₹8.29 Lakh |
| Net Profit | -₹10.42 Cr |
| Other Comprehensive Income | ₹0 |
| Total Comprehensive Income | -₹10.42 Cr |
| EBITDA (computed) | -₹5.17 Cr |
| Basic EPS | ₹-0.16 |
| Diluted EPS | ₹-0.15 |
| Metrics | FY 2026 |
|---|---|
| Total Assets | ₹388.65 Cr |
| Non-current Assets | ₹359.07 Cr |
| Current Assets | ₹29.58 Cr |
| Property, Plant & Equipment | ₹2.91 Lakh |
| Inventories | ₹41.95 Lakh |
| Trade Receivables | ₹20.71 Cr |
| Cash & Equivalents | ₹1.14 Cr |
| Equity (Net Worth) | ₹338.13 Cr |
| Equity Share Capital | ₹65.45 Cr |
| Borrowings (Non-current) | ₹12.97 Cr |
| Borrowings (Current) | ₹0 |
| Total Debt (computed) | ₹12.97 Cr |
| Current Liabilities | ₹11.85 Cr |
| Total Liabilities | ₹50.52 Cr |
| Metrics | FY 2026 |
|---|---|
| Operating Cash Flow | -₹2.91 Cr |
| Investing Cash Flow | -₹13.27 Cr |
| Financing Cash Flow | ₹17.02 Cr |
| Capital Expenditure | ₹2.93 Lakh |
| Free Cash Flow (computed) | -₹2.94 Cr |
| Dividends Paid | ₹27.44 Lakh |
| Net Change in Cash | ₹85.11 Lakh |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|---|---|---|---|
| Revenue from Operations | ₹4.11 Cr | ₹1.32 Cr | ₹7.43 Cr | ₹4.54 Cr |
| Other Income | ₹43.4 Lakh | ₹85.67 Lakh | ₹1.43 Cr | ₹80.4 Lakh |
| Total Income | ₹4.54 Cr | ₹2.17 Cr | ₹8.86 Cr | ₹5.35 Cr |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹2.77 Cr | ₹1.37 Cr | ₹4.63 Cr | ₹3.19 Cr |
| Changes in Inventories | ₹4.58 Lakh | -₹40.03 Lakh | ₹0 | ₹0 |
| Employee Benefit Expense | ₹52.39 Lakh | ₹61.81 Lakh | ₹45.46 Lakh | ₹41.75 Lakh |
| Finance Costs | ₹1.27 Cr | ₹95.89 Lakh | ₹1.12 Cr | ₹1.31 Cr |
| Depreciation & Amortisation | ₹43.39 Lakh | ₹8.16 Lakh | ₹8.16 Lakh | ₹8.16 Lakh |
| Other Expenses | ₹9.67 Cr | ₹1.05 Cr | ₹1.19 Cr | ₹56.8 Lakh |
| Total Expenses | ₹14.71 Cr | ₹3.67 Cr | ₹7.48 Cr | ₹5.56 Cr |
| Profit Before Exceptional Items & Tax | -₹10.17 Cr | -₹1.5 Cr | ₹1.38 Cr | -₹21.55 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹10.17 Cr | -₹1.5 Cr | ₹1.38 Cr | -₹21.55 Lakh |
| Total Tax Expense | -₹1.19 Cr | ₹16.77 Lakh | ₹54.05 Lakh | ₹39.38 Lakh |
| Net Profit | -₹8.98 Cr | -₹1.67 Cr | ₹83.77 Lakh | -₹60.93 Lakh |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | -₹8.98 Cr | -₹1.67 Cr | ₹83.77 Lakh | -₹60.93 Lakh |
| EBITDA (computed) | -₹8.47 Cr | -₹46.11 Lakh | ₹2.58 Cr | ₹1.17 Cr |
| Basic EPS | ₹-0.14 | ₹-0.03 | ₹0.13 | ₹-0.09 |
| Diluted EPS | ₹-0.13 | ₹-0.03 | ₹0.13 | ₹-0.09 |
Shareholding Pattern of Fischer Medical Ventures Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 62.15%, foreign institutional investors hold 4.97%, domestic institutional investors hold 1.38%, retail and other public shareholders hold 31.50% of Fischer Medical Ventures Limited. The company had 23,269 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jul 2025 | Jun 2025 | |
|---|---|---|---|---|---|
| Promoters | 62.15% | 61.80% | 61.80% | 61.80% | 61.80% |
| Public | 37.85% | 38.20% | 38.20% | 38.20% | 38.20% |
Board & Governance of Fischer Medical Ventures Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Fischer Medical Ventures Limited has 8 directors - 6 independent and 2 executive. The board is chaired by RAVINDRAN GOVINDAN.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| RAVINDRAN GOVINDAN | Executive Director · MD · Chairperson | 2024-05-04 | 1 |
| SVETLANA RAO RAVIWADA | Executive Director | 2024-05-04 | 1 |
| KHAIRY JAMALUDDIN ABU BAKAR | Non-Executive - Independent Director | 2024-05-04 | 1 |
| SANJAY JAYANTILAL JAIN | Non-Executive - Independent Director | 2021-10-12 | 1 |
| ROBERTO M PADGDANGANAN | Non-Executive - Independent Director | 2024-07-05 | 1 |
| JAYA ANKUR SINGHANIA | Non-Executive - Independent Director | 2025-03-26 | 4 |
| CHAN SING EN | Non-Executive - Independent Director | 2025-10-28 | 1 |
| SYED JALALUDIN | Non-Executive - Independent Director | 2025-11-30 | 1 |
| Committee | Members |
|---|---|
| Audit Committee | KHAIRY JAMALUDDIN ABU BAKAR (Chairperson), SANJAY JAYANTILAL JAIN, RAVINDRAN GOVINDAN, JAYA ANKUR SINGHANIA, ROBERTO M PADGDANGANAN, CHAN SING EN, SYED JALALUDIN |
| Nomination and remuneration committee | KHAIRY JAMALUDDIN ABU BAKAR (Chairperson), ROBERTO M PADGDANGANAN, JAYA ANKUR SINGHANIA, RAVINDRAN GOVINDAN, SYED JALALUDIN |
| Stakeholders Relationship Committee | JAYA ANKUR SINGHANIA (Chairperson), SVETLANA RAO RAVIWADA, RAVINDRAN GOVINDAN |
| Risk Management Committee | SVETLANA RAO RAVIWADA (Chairperson), RAVINDRAN GOVINDAN, KHAIRY JAMALUDDIN ABU BAKAR, JAYA ANKUR SINGHANIA, CHAN SING EN |
| Corporate Social Responsibility Committee | SVETLANA RAO RAVIWADA (Chairperson), ROBERTO M PADGDANGANAN, JAYA ANKUR SINGHANIA, RAVINDRAN GOVINDAN, CHAN SING EN |
Charges & Borrowings of Fischer Medical Ventures Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Mar 2025 | Others | ₹25 Cr | Open |
| 30 May 2005 | Sundaram Finance Limited | ₹20.63 Lakh | Satisfied |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has a workforce of 0 employees as of Sep 26, 2025.
Employee Count & EPFO Data of Fischer Medical Ventures Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Fischer Medical Ventures Limited
GSTIN & GST Filing Data of Fischer Medical Ventures Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Fischer Medical Ventures Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Fischer Medical Ventures Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Fischer Medical Ventures Limited
MSME Payment Delays by Fischer Medical Ventures Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Fischer Medical Ventures Limited
Subsidiaries & Group Companies of Fischer Medical Ventures Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Fischer Medical Ventures Limited with ownership details.
MCA Filings & Documents of Fischer Medical Ventures Limited
MCA Filings & Documents of Fischer Medical Ventures Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Fischer Medical Ventures Limited
Frequently Asked Questions about Fischer Medical Ventures Limited
Fischer Medical Ventures Limited is an active public limited company in the chemicals and materials sector based in Pedagantyada, Andhra Pradesh, India. It was incorporated on 22 March 1993 (33+ years old) and is registered under CIN L86900AP1993PLC118162. Listed on BSE: 524743.
Fischer Medical Ventures Limited reported revenue of ₹17.95 Lakh for FY 2023.
The current directors of Fischer Medical Ventures Limited are:
The primary industry of Fischer Medical Ventures Limited is chemicals and materials. The company specifically operates in chemical distribution and retail. The company is currently active in this sector.
Yes. Fischer Medical Ventures Limited is listed on BSE with code 524743.
Fischer Medical Ventures Limited can be reached at the registered office: Survey No. 4802 Ap Medtech Zone Nadupura Village, Pedagantyadu Mandal Visakhapatnam, Pedagantyada, Andhra Pradesh, India – 530031, or through the website fischerchemic.in.